Statement Of Financial Position [Abstract]

BerGenBio - Filing #2615544

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Cash and cash equivalents
436,646,000 NOK
721,641,000 NOK
253,586,000 NOK
Assets
450,236,000 NOK
738,200,000 NOK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
8,846,000 NOK
8,726,000 NOK
Share premium
335,195,000 NOK
628,231,000 NOK
Equity
384,426,000 NOK
40,386,000 NOK
335,195,000 NOK
8,846,000 NOK
670,229,000 NOK
8,726,000 NOK
33,272,000 NOK
628,231,000 NOK
219,754,000 NOK
25,860,000 NOK
187,786,000 NOK
6,108,000 NOK
Liabilities [abstract]
Liabilities
65,810,000 NOK
67,971,000 NOK
Equity and liabilities
450,236,000 NOK
738,200,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.